Crosstree Capital Partners is a sector-focused investment bank, providing M&A advisory and growth capital solutions exclusively to life sciences companies. Our industry focus affords our clients with several advantages, including:
Increased Confidentiality - Our relationships with key decision-makers help to reduce the number of people aware of potential transactions and accelerate the marketing timeline.
Faster Time to Market - By focusing exclusively on an industry, our bankers have a limited learning curve in understanding our clients’ business models. Furthermore, our ability to leverage pre-developed financial models and offering templates designed specifically for an industry can significantly reduce time-to-market.
Informed Decision Making - Crosstree provides our clients with insight into current valuation dynamics with information that simply isn’t available in the public domain. Our deep domain expertise allows us to credibly demonstrate potential synergies and considerations to interested suitors which literally adds value to the transaction beyond simply running an auction process.